A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2019
Price : $35 *
At a glance
- Drugs Metformin (Primary) ; Sirolimus (Primary)
- Indications Solid tumours
- Focus Biomarker; Pharmacodynamics
- 18 Apr 2019 Status changed from discontinued to completed.
- 31 Aug 2018 Biomarkers information updated
- 07 Mar 2018 Planned End Date changed from 1 Jul 2018 to 1 Jul 2019.